Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Inflammatory Bowel Diseases

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 167 articles:
HTML format
Text format



Single Articles


    January 2018
  1. MENDALL M, Harpsoe MC, Kumar D, Andersson M, et al
    Relation of body mass index to risk of developing inflammatory bowel disease amongst women in the Danish National Birth Cohort.
    PLoS One. 2018;13:e0190600.
    PubMed     Text format     Abstract available


  2. MINTZ M, Khair S, Grewal S, LaComb JF, et al
    Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
    PLoS One. 2018;13:e0190997.
    PubMed     Text format     Abstract available


  3. DE BRUYN JR, Becker MA, Steenkamer J, Wildenberg ME, et al
    Intestinal fibrosis is associated with lack of response to Infliximab therapy in Crohn's disease.
    PLoS One. 2018;13:e0190999.
    PubMed     Text format     Abstract available


  4. GARCIA-SANJUAN S, Lillo-Crespo M, Richart-Martinez M, Sanjuan-Quiles A, et al
    Healthcare professionals' views of the experiences of individuals living with Crohn's Disease in Spain. A qualitative study.
    PLoS One. 2018;13:e0190980.
    PubMed     Text format     Abstract available


  5. BALBAS-MARTINEZ V, Ruiz-Cerda L, Irurzun-Arana I, Gonzalez-Garcia I, et al
    A systems pharmacology model for inflammatory bowel disease.
    PLoS One. 2018;13:e0192949.
    PubMed     Text format     Abstract available


  6. MIJAC D, Vukovic-Petrovic I, Mijac V, Perovic V, et al
    MDR1 gene polymorphisms are associated with ulcerative colitis in a cohort of Serbian patients with inflammatory bowel disease.
    PLoS One. 2018;13:e0194536.
    PubMed     Text format     Abstract available


  7. BUHNER S, Hahne H, Hartwig K, Li Q, et al
    Protease signaling through protease activated receptor 1 mediate nerve activation by mucosal supernatants from irritable bowel syndrome but not from ulcerative colitis patients.
    PLoS One. 2018;13:e0193943.
    PubMed     Text format     Abstract available


  8. CHIBA H, Kakuta Y, Kinouchi Y, Kawai Y, et al
    Allele-specific DNA methylation of disease susceptibility genes in Japanese patients with inflammatory bowel disease.
    PLoS One. 2018;13:e0194036.
    PubMed     Text format     Abstract available


  9. KAMM F, Strauch U, Degenhardt F, Lopez R, et al
    Serum anti-glycan-antibodies in relatives of patients with inflammatory bowel disease.
    PLoS One. 2018;13:e0194222.
    PubMed     Text format     Abstract available


  10. KOVACS G, Sipeki N, Suga B, Tornai T, et al
    Significance of serological markers in the disease course of ulcerative colitis in a prospective clinical cohort of patients.
    PLoS One. 2018;13:e0194166.
    PubMed     Text format     Abstract available


  11. MORAN CJ, Huang H, Rivas M, Kaplan JL, et al
    Genetic variants in cellular transport do not affect mesalamine response in ulcerative colitis.
    PLoS One. 2018;13:e0192806.
    PubMed     Text format     Abstract available


  12. SAITO H, Hirayama A, Umemura T, Joshita S, et al
    Association between KIR-HLA combination and ulcerative colitis and Crohn's disease in a Japanese population.
    PLoS One. 2018;13:e0195778.
    PubMed     Text format     Abstract available


  13. WALJEE AK, Wiitala WL, Govani S, Stidham R, et al
    Correction: Corticosteroid Use and Complications in a US Inflammatory Bowel Disease Cohort.
    PLoS One. 2018;13:e0197341.
    PubMed     Text format     Abstract available


  14. KUTSUNA R, Tomida J, Morita Y, Kawamura Y, et al
    Paraclostridium bifermentans exacerbates pathosis in a mouse model of ulcerative colitis.
    PLoS One. 2018;13:e0197668.
    PubMed     Text format     Abstract available


  15. BOURGONJE AR, von Martels JZH, de Vos P, Faber KN, et al
    Increased fecal calprotectin levels in Crohn's disease correlate with elevated serum Th1- and Th17-associated cytokines.
    PLoS One. 2018;13:e0193202.
    PubMed     Text format     Abstract available


  16. ANAND U, Yiangou Y, Akbar A, Quick T, et al
    Glucagon-like peptide 1 receptor (GLP-1R) expression by nerve fibres in inflammatory bowel disease and functional effects in cultured neurons.
    PLoS One. 2018;13:e0198024.
    PubMed     Text format     Abstract available


  17. TIWARI V, Kedia S, Garg SK, Rampal R, et al
    CD4+ CD25+ FOXP3+ T cell frequency in the peripheral blood is a biomarker that distinguishes intestinal tuberculosis from Crohn's disease.
    PLoS One. 2018;13:e0193433.
    PubMed     Text format     Abstract available


  18. GRAY MA, Chao CY, Staudacher HM, Kolosky NA, et al
    Anti-TNFalpha therapy in IBD alters brain activity reflecting visceral sensory function and cognitive-affective biases.
    PLoS One. 2018;13:e0193542.
    PubMed     Text format     Abstract available


  19. STEWART DC, Berrie D, Li J, Liu X, et al
    Quantitative assessment of intestinal stiffness and associations with fibrosis in human inflammatory bowel disease.
    PLoS One. 2018;13:e0200377.
    PubMed     Text format     Abstract available


  20. YANG BR, Choi NK, Kim MS, Chun J, et al
    Prevalence of extraintestinal manifestations in Korean inflammatory bowel disease patients.
    PLoS One. 2018;13:e0200363.
    PubMed     Text format     Abstract available


  21. GOVANI SM, Higgins PDR, Rubenstein JH, Stidham RW, et al
    CT utilization abruptly increases at age 18 among patients with inflammatory bowel diseases in the hospital.
    PLoS One. 2018;13:e0195022.
    PubMed     Text format     Abstract available


  22. CHEN CH, Lin CL, Jeng LB
    Association between chronic pancreatitis and urolithiasis: A population-based cohort study.
    PLoS One. 2018;13:e0194019.
    PubMed     Text format     Abstract available


  23. DECLERCQ V, Langille MGI, Van Limbergen J
    Differences in adiposity and diet quality among individuals with inflammatory bowel disease in Eastern Canada.
    PLoS One. 2018;13:e0200580.
    PubMed     Text format     Abstract available


  24. PEIRAVAN A, Bertolini F, Rothschild MF, Simpson KW, et al
    Genome-wide association studies of inflammatory bowel disease in German shepherd dogs.
    PLoS One. 2018;13:e0200685.
    PubMed     Text format     Abstract available


  25. VAN DER STAR BJ, van Dijk CE, Zock JP, Smit LAM, et al
    Healthcare utilisation prior to the diagnosis of inflammatory bowel diseases and the influence of livestock exposure: A longitudinal case-control study.
    PLoS One. 2018;13:e0195305.
    PubMed     Text format     Abstract available


    January 2017
  26. COSTA PEREIRA C, Duraes C, Coelho R, Gracio D, et al
    Association between Polymorphisms in Antioxidant Genes and Inflammatory Bowel Disease.
    PLoS One. 2017;12:e0169102.
    PubMed     Text format     Abstract available


  27. NISHIDA Y, Hosomi S, Yamagami H, Yukawa T, et al
    Neutrophil-to-Lymphocyte Ratio for Predicting Loss of Response to Infliximab in Ulcerative Colitis.
    PLoS One. 2017;12:e0169845.
    PubMed     Text format     Abstract available


  28. VRAKAS S, Mountzouris KC, Michalopoulos G, Karamanolis G, et al
    Intestinal Bacteria Composition and Translocation of Bacteria in Inflammatory Bowel Disease.
    PLoS One. 2017;12:e0170034.
    PubMed     Text format     Abstract available



  29. Correction: Inflammatory Bowel Disease: How Effective Is TNF-alpha Suppression?
    PLoS One. 2017;12:e0170865.
    PubMed     Text format     Abstract available


  30. SINGH H, Nugent Z, Yu BN, Lix LM, et al
    Hospital discharge abstracts have limited accuracy in identifying occurrence of Clostridium difficile infections among hospitalized individuals with inflammatory bowel disease: A population-based study.
    PLoS One. 2017;12:e0171266.
    PubMed     Text format     Abstract available


  31. KUO B, Bhasin M, Jacquart J, Scult MA, et al
    Correction: Genomic and Clinical Effects Associated with a Relaxation Response Mind-Body Intervention in Patients with Irritable Bowel Syndrome and Inflammatory Bowel Disease.
    PLoS One. 2017;12:e0172872.
    PubMed     Text format     Abstract available


  32. RANJHA R, Meena NK, Singh A, Ahuja V, et al
    Association of miR-196a-2 and miR-499 variants with ulcerative colitis and their correlation with expression of respective miRNAs.
    PLoS One. 2017;12:e0173447.
    PubMed     Text format     Abstract available


  33. LEWIS A, Felice C, Kumagai T, Lai C, et al
    The miR-200 family is increased in dysplastic lesions in ulcerative colitis patients.
    PLoS One. 2017;12:e0173664.
    PubMed     Text format     Abstract available


  34. BOR R, Farkas K, Fabian A, Balint A, et al
    Clinical role, optimal timing and frequency of serum infliximab and anti-infliximab antibody level measurements in patients with inflammatory bowel disease.
    PLoS One. 2017;12:e0172916.
    PubMed     Text format     Abstract available


  35. TOROK HP, Bellon V, Konrad A, Lacher M, et al
    Functional Toll-Like Receptor (TLR)2 polymorphisms in the susceptibility to inflammatory bowel disease.
    PLoS One. 2017;12:e0175180.
    PubMed     Text format     Abstract available


  36. NIRVANAPPA AC, Mohan CD, Rangappa S, Ananda H, et al
    Correction: Novel Synthetic Oxazines Target NF-kappaB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo.
    PLoS One. 2017;12:e0175659.
    PubMed     Text format     Abstract available


  37. SULLIVAN E, Piercy J, Waller J, Black CM, et al
    Assessing gastroenterologist and patient acceptance of biosimilars in ulcerative colitis and Crohn's disease across Germany.
    PLoS One. 2017;12:e0175826.
    PubMed     Text format     Abstract available


  38. PATEL H, Lissoos T, Rubin DT
    Indicators of suboptimal biologic therapy over time in patients with ulcerative colitis and Crohn's disease in the United States.
    PLoS One. 2017;12:e0175099.
    PubMed     Text format     Abstract available


  39. MURTHY SK, James PD, Antonova L, Chalifoux M, et al
    High end of life health care costs and hospitalization burden in inflammatory bowel disease patients: A population-based study.
    PLoS One. 2017;12:e0177211.
    PubMed     Text format     Abstract available


  40. PUGAZHENDHI S, Baskaran K, Santhanam S, Ramakrishna BS, et al
    Association of ATG16L1 gene haplotype with inflammatory bowel disease in Indians.
    PLoS One. 2017;12:e0178291.
    PubMed     Text format     Abstract available


  41. TIMMER A, Peplies J, Westphal M, Kaltz B, et al
    Transition from pediatric to adult medical care - A survey in young persons with inflammatory bowel disease.
    PLoS One. 2017;12:e0177757.
    PubMed     Text format     Abstract available


  42. SCHIEFFER KM, Bruffy SM, Rauscher R, Koltun WA, et al
    Reduced total serum bilirubin levels are associated with ulcerative colitis.
    PLoS One. 2017;12:e0179267.
    PubMed     Text format     Abstract available


  43. DE PALMA GD, Colavita I, Zambrano G, Giglio MC, et al
    Detection of colonic dysplasia in patients with ulcerative colitis using a targeted fluorescent peptide and confocal laser endomicroscopy: A pilot study.
    PLoS One. 2017;12:e0180509.
    PubMed     Text format     Abstract available


  44. CUI Y, Zhu C, Ming Z, Cao J, et al
    Molecular mechanisms by which casein glycomacropeptide maintains internal homeostasis in mice with experimental ulcerative colitis.
    PLoS One. 2017;12:e0181075.
    PubMed     Text format     Abstract available


  45. VILLORIA A, Garcia V, Dosal A, Moreno L, et al
    Fatigue in out-patients with inflammatory bowel disease: Prevalence and predictive factors.
    PLoS One. 2017;12:e0181435.
    PubMed     Text format     Abstract available


  46. VITALE S, Strisciuglio C, Pisapia L, Miele E, et al
    Cytokine production profile in intestinal mucosa of paediatric inflammatory bowel disease.
    PLoS One. 2017;12:e0182313.
    PubMed     Text format     Abstract available


  47. PITTET V, Vaucher C, Froehlich F, Burnand B, et al
    Patient self-reported concerns in inflammatory bowel diseases: A gender-specific subjective quality-of-life indicator.
    PLoS One. 2017;12:e0171864.
    PubMed     Text format     Abstract available


  48. HAMPSHIRE T, Menys A, Jaffer A, Bhatnagar G, et al
    A Probabilistic Method for Estimation of Bowel Wall Thickness in MR Colonography.
    PLoS One. 2017;12:e0168317.
    PubMed     Text format     Abstract available


  49. WILLIAMS AD, Korolkova OY, Sakwe AM, Geiger TM, et al
    Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease.
    PLoS One. 2017;12:e0179710.
    PubMed     Text format     Abstract available


  50. IJAZ UZ, Quince C, Hanske L, Loman N, et al
    The distinct features of microbial 'dysbiosis' of Crohn's disease do not occur to the same extent in their unaffected, genetically-linked kindred.
    PLoS One. 2017;12:e0172605.
    PubMed     Text format     Abstract available


  51. STIDHAM RW, Wu J, Shi J, Lubman DM, et al
    Serum Glycoproteome Profiles for Distinguishing Intestinal Fibrosis from Inflammation in Crohn's Disease.
    PLoS One. 2017;12:e0170506.
    PubMed     Text format     Abstract available


  52. MICIC D, Gaetano JN, Rubin JN, Cohen RD, et al
    Factors associated with readmission to the hospital within 30 days in patients with inflammatory bowel disease.
    PLoS One. 2017;12:e0182900.
    PubMed     Text format     Abstract available


  53. PEREIRA SR, Pereira R, Figueiredo I, Freitas V, et al
    Comparison of anti-inflammatory activities of an anthocyanin-rich fraction from Portuguese blueberries (Vaccinium corymbosum L.) and 5-aminosalicylic acid in a TNBS-induced colitis rat model.
    PLoS One. 2017;12:e0174116.
    PubMed     Text format     Abstract available


  54. DIAS CC, Pereira Rodrigues P, Fernandes S, Portela F, et al
    The risk of disabling, surgery and reoperation in Crohn's disease - A decision tree-based approach to prognosis.
    PLoS One. 2017;12:e0172165.
    PubMed     Text format     Abstract available


  55. SABE VT, Basson AR, Jordaan E, Mazinu M, et al
    The association between environmental exposures during childhood and the subsequent development of Crohn's disease: A score analysis approach.
    PLoS One. 2017;12:e0171742.
    PubMed     Text format     Abstract available


  56. MONASTA L, Pierobon C, Princivalle A, Martelossi S, et al
    Inflammatory bowel disease and patterns of volatile organic compounds in the exhaled breath of children: A case-control study using Ion Molecule Reaction-Mass Spectrometry.
    PLoS One. 2017;12:e0184118.
    PubMed     Text format     Abstract available


  57. SARID O, Slonim-Nevo V, Pereg A, Friger M, et al
    Coping strategies, satisfaction with life, and quality of life in Crohn's disease: A gender perspective using structural equation modeling analysis.
    PLoS One. 2017;12:e0172779.
    PubMed     Text format     Abstract available


  58. PALMIERI O, Bossa F, Valvano MR, Corritore G, et al
    Crohn's Disease Localization Displays Different Predisposing Genetic Variants.
    PLoS One. 2017;12:e0168821.
    PubMed     Text format     Abstract available


  59. OKAHARA K, Nagata N, Shimada T, Joya A, et al
    Colonic cytomegalovirus detection by mucosal PCR and antiviral therapy in ulcerative colitis.
    PLoS One. 2017;12:e0183951.
    PubMed     Text format     Abstract available


  60. RANJHA R, Meena NK, Singh A, Ahuja V, et al
    Correction: Association of miR-196a-2 and miR-499 variants with ulcerative colitis and their correlation with expression of respective miRNAs.
    PLoS One. 2017;12:e0184701.
    PubMed     Text format     Abstract available


  61. IRWIN J, Ferguson E, Simms LA, Hanigan K, et al
    A rolling phenotype in Crohn's disease.
    PLoS One. 2017;12:e0174954.
    PubMed     Text format     Abstract available


  62. MENGHINI P, Di Martino L, Lopetuso LR, Corridoni D, et al
    A novel model of colitis-associated cancer in SAMP1/YitFc mice with Crohn's disease-like ileitis.
    PLoS One. 2017;12:e0174121.
    PubMed     Text format     Abstract available


  63. SHIMADA T, Nagata N, Okahara K, Joya A, et al
    PCR detection of human herpesviruses in colonic mucosa of individuals with inflammatory bowel disease: Comparison with individuals with immunocompetency and HIV infection.
    PLoS One. 2017;12:e0184699.
    PubMed     Text format     Abstract available


  64. OH K, Oh EH, Baek S, Song EM, et al
    Elevated C-reactive protein level during clinical remission can predict poor outcomes in patients with Crohn's disease.
    PLoS One. 2017;12:e0179266.
    PubMed     Text format     Abstract available


  65. AL-JARALLAH A, Oriowo M
    The effect of sphingosine-1-phosphate on colonic smooth muscle contractility: Modulation by TNBS-induced colitis.
    PLoS One. 2017;12:e0170792.
    PubMed     Text format     Abstract available


  66. TOYONAGA T, Kobayashi T, Nakano M, Saito E, et al
    Usefulness of fecal calprotectin for the early prediction of short-term outcomes of remission-induction treatments in ulcerative colitis in comparison with two-item patient-reported outcome.
    PLoS One. 2017;12:e0185131.
    PubMed     Text format     Abstract available


  67. KIM Y, Wu AG, Jaja-Chimedza A, Graf BL, et al
    Isothiocyanate-enriched moringa seed extract alleviates ulcerative colitis symptoms in mice.
    PLoS One. 2017;12:e0184709.
    PubMed     Text format     Abstract available


  68. BAMBA S, Sasaki M, Takaoka A, Takahashi K, et al
    Sarcopenia is a predictive factor for intestinal resection in admitted patients with Crohn's disease.
    PLoS One. 2017;12:e0180036.
    PubMed     Text format     Abstract available


  69. PENG YC, Lin CL, Sung FC
    The association between cholecystectomy and colorectal neoplasm in inflammatory bowel diseases: A population-based cohort study.
    PLoS One. 2017;12:e0177745.
    PubMed     Text format     Abstract available


  70. OH EH, Oh K, Han M, Seo H, et al
    Early anti-TNF/immunomodulator therapy is associated with better long-term clinical outcomes in Asian patients with Crohn's disease with poor prognostic factors.
    PLoS One. 2017;12:e0177479.
    PubMed     Text format     Abstract available


  71. SOMASUNDARAM R, Fernandes S, Deuring JJ, de Haar C, et al
    Analysis of SHIP1 expression and activity in Crohn's disease patients.
    PLoS One. 2017;12:e0182308.
    PubMed     Text format     Abstract available


  72. HENNENBERG EM, Eyking A, Reis H, Cario E, et al
    MDR1A deficiency restrains tumor growth in murine colitis-associated carcinogenesis.
    PLoS One. 2017;12:e0180834.
    PubMed     Text format     Abstract available


  73. ANDERSSON E, Bergemalm D, Kruse R, Neumann G, et al
    Subphenotypes of inflammatory bowel disease are characterized by specific serum protein profiles.
    PLoS One. 2017;12:e0186142.
    PubMed     Text format     Abstract available


  74. PILLAI N, Dusheiko M, Burnand B, Pittet V, et al
    A systematic review of cost-effectiveness studies comparing conventional, biological and surgical interventions for inflammatory bowel disease.
    PLoS One. 2017;12:e0185500.
    PubMed     Text format     Abstract available


  75. TAKAYASU L, Suda W, Watanabe E, Fukuda S, et al
    A 3-dimensional mathematical model of microbial proliferation that generates the characteristic cumulative relative abundance distributions in gut microbiomes.
    PLoS One. 2017;12:e0180863.
    PubMed     Text format     Abstract available


  76. HAN YM, Koh J, Kim JW, Lee C, et al
    NF-kappa B activation correlates with disease phenotype in Crohn's disease.
    PLoS One. 2017;12:e0182071.
    PubMed     Text format     Abstract available


  77. SJOBERG F, Barkman C, Nookaew I, Ostman S, et al
    Low-complexity microbiota in the duodenum of children with newly diagnosed ulcerative colitis.
    PLoS One. 2017;12:e0186178.
    PubMed     Text format     Abstract available


  78. CHEN L, Zhou Z, Yang Y, Chen N, et al
    Therapeutic effect of imiquimod on dextran sulfate sodium-induced ulcerative colitis in mice.
    PLoS One. 2017;12:e0186138.
    PubMed     Text format     Abstract available


  79. MORTENSEN JH, Manon-Jensen T, Jensen MD, Hagglund P, et al
    Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
    PLoS One. 2017;12:e0185855.
    PubMed     Text format     Abstract available


  80. PERRY T, Laffin M, Fedorak RN, Thiesen A, et al
    Ileocolic resection is associated with increased susceptibility to injury in a murine model of colitis.
    PLoS One. 2017;12:e0184660.
    PubMed     Text format     Abstract available


  81. SCALDAFERRI F, D'Ambrosio D, Holleran G, Poscia A, et al
    Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab.
    PLoS One. 2017;12:e0186575.
    PubMed     Text format     Abstract available


  82. FAGAGNINI S, Heinrich H, Rossel JB, Biedermann L, et al
    Risk factors for gallstones and kidney stones in a cohort of patients with inflammatory bowel diseases.
    PLoS One. 2017;12:e0185193.
    PubMed     Text format     Abstract available


  83. FUKUDA T, Naganuma M, Sugimoto S, Nanki K, et al
    The risk factor of clinical relapse in ulcerative colitis patients with low dose 5-aminosalicylic acid as maintenance therapy: A report from the IBD registry.
    PLoS One. 2017;12:e0187737.
    PubMed     Text format     Abstract available


  84. SEKIZUKA T, Ogasawara Y, Ohkusa T, Kuroda M, et al
    Characterization of Fusobacterium varium Fv113-g1 isolated from a patient with ulcerative colitis based on complete genome sequence and transcriptome analysis.
    PLoS One. 2017;12:e0189319.
    PubMed     Text format     Abstract available


  85. LIN WC, Chang CW, Chen MJ, Chu CH, et al
    Challenges in the diagnosis of ulcerative colitis with concomitant bacterial infections and chronic infectious colitis.
    PLoS One. 2017;12:e0189377.
    PubMed     Text format     Abstract available


  86. HOLTMAN GA, Lisman-van Leeuwen Y, Kollen BJ, Norbruis OF, et al
    Diagnostic test strategies in children at increased risk of inflammatory bowel disease in primary care.
    PLoS One. 2017;12:e0189111.
    PubMed     Text format     Abstract available


  87. WILLIAMS AD, Korolkova OY, Sakwe AM, Geiger TM, et al
    Correction: Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease.
    PLoS One. 2017;12:e0189551.
    PubMed     Text format     Abstract available


  88. SARGIN ZG, Erin N, Tazegul G, Elpek GO, et al
    Profound loss of neprilysin accompanied by decreased levels of neuropeptides and increased CRP in ulcerative colitis.
    PLoS One. 2017;12:e0189526.
    PubMed     Text format     Abstract available


  89. LEE JH, Kim TJ, Kim ER, Hong SN, et al
    Measurements of 6-thioguanine nucleotide levels with TPMT and NUDT15 genotyping in patients with Crohn's disease.
    PLoS One. 2017;12:e0188925.
    PubMed     Text format     Abstract available


    January 2016
  90. HU D, Zhang D, Zheng S, Guo M, et al
    Association of Ulcerative Colitis with FUT2 and FUT3 Polymorphisms in Patients from Southeast China.
    PLoS One. 2016;11:e0146557.
    PubMed     Text format     Abstract available


  91. BAUMGART DC, le Claire M
    The Expenditures for Academic Inpatient Care of Inflammatory Bowel Disease Patients Are Almost Double Compared with Average Academic Gastroenterology and Hepatology Cases and Not Fully Recovered by Diagnosis-Related Group (DRG) Proceeds.
    PLoS One. 2016;11:e0147364.
    PubMed     Text format     Abstract available


  92. TIMMS VJ, Daskalopoulos G, Mitchell HM, Neilan BA, et al
    The Association of Mycobacterium avium subsp. paratuberculosis with Inflammatory Bowel Disease.
    PLoS One. 2016;11:e0148731.
    PubMed     Text format     Abstract available


  93. BLACK CM, Yu E, McCann E, Kachroo S, et al
    Dose Escalation and Healthcare Resource Use among Ulcerative Colitis Patients Treated with Adalimumab in English Hospitals: An Analysis of Real-World Data.
    PLoS One. 2016;11:e0149692.
    PubMed     Text format     Abstract available


  94. WATANABE Y, Arase S, Nagaoka N, Kawai M, et al
    Chronic Psychological Stress Disrupted the Composition of the Murine Colonic Microbiota and Accelerated a Murine Model of Inflammatory Bowel Disease.
    PLoS One. 2016;11:e0150559.
    PubMed     Text format     Abstract available


  95. PITTET V, Vaucher C, Maillard MH, Girardin M, et al
    Information Needs and Concerns of Patients with Inflammatory Bowel Disease: What Can We Learn from Participants in a Bilingual Clinical Cohort?
    PLoS One. 2016;11:e0150620.
    PubMed     Text format     Abstract available


  96. THERKELSEN SP, Hetland G, Lyberg T, Lygren I, et al
    Effect of a Medicinal Agaricus blazei Murill-Based Mushroom Extract, AndoSan, on Symptoms, Fatigue and Quality of Life in Patients with Ulcerative Colitis in a Randomized Single-Blinded Placebo Controlled Study.
    PLoS One. 2016;11:e0150191.
    PubMed     Text format     Abstract available


  97. TERRAGNI R, Morselli-Labate AM, Vignoli M, Bottero E, et al
    Is Serum Total LDH Evaluation Able to Differentiate between Alimentary Lymphoma and Inflammatory Bowel Disease in a Real World Clinical Setting?
    PLoS One. 2016;11:e0151641.
    PubMed     Text format     Abstract available


  98. NAGY E, Rodriguiz RM, Wetsel WC, MacIver NJ, et al
    Reproduction and Growth in a Murine Model of Early Life-Onset Inflammatory Bowel Disease.
    PLoS One. 2016;11:e0152764.
    PubMed     Text format     Abstract available


  99. NIU J, Miao J, Tang Y, Nan Q, et al
    Identification of Environmental Factors Associated with Inflammatory Bowel Disease in a Southwestern Highland Region of China: A Nested Case-Control Study.
    PLoS One. 2016;11:e0153524.
    PubMed     Text format     Abstract available


  100. VAN DER VALK ME, Mangen MJ, Severs M, van der Have M, et al
    Evolution of Costs of Inflammatory Bowel Disease over Two Years of Follow-Up.
    PLoS One. 2016;11:e0142481.
    PubMed     Text format     Abstract available


  101. ROTH S, Spalinger MR, Gottier C, Biedermann L, et al
    Bilberry-Derived Anthocyanins Modulate Cytokine Expression in the Intestine of Patients with Ulcerative Colitis.
    PLoS One. 2016;11:e0154817.
    PubMed     Text format     Abstract available


  102. WIESE DM, Horst SN, Brown CT, Allaman MM, et al
    Serum Fatty Acids Are Correlated with Inflammatory Cytokines in Ulcerative Colitis.
    PLoS One. 2016;11:e0156387.
    PubMed     Text format     Abstract available


  103. VOGELIN M, Biedermann L, Frei P, Vavricka SR, et al
    The Impact of Azathioprine-Associated Lymphopenia on the Onset of Opportunistic Infections in Patients with Inflammatory Bowel Disease.
    PLoS One. 2016;11:e0155218.
    PubMed     Text format     Abstract available


  104. SHI Y, Dong Y, Huang W, Zhu D, et al
    Fecal Microbiota Transplantation for Ulcerative Colitis: A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0157259.
    PubMed     Text format     Abstract available


  105. WALJEE AK, Wiitala WL, Govani S, Stidham R, et al
    Corticosteroid Use and Complications in a US Inflammatory Bowel Disease Cohort.
    PLoS One. 2016;11:e0158017.
    PubMed     Text format     Abstract available


  106. ZHANG T, Cui B, Li P, He Z, et al
    Short-Term Surveillance of Cytokines and C-Reactive Protein Cannot Predict Efficacy of Fecal Microbiota Transplantation for Ulcerative Colitis.
    PLoS One. 2016;11:e0158227.
    PubMed     Text format     Abstract available


  107. ZUNDLER S, Caioni M, Muller M, Strauch U, et al
    K+ Channel Inhibition Differentially Regulates Migration of Intestinal Epithelial Cells in Inflamed vs. Non-Inflamed Conditions in a PI3K/Akt-Mediated Manner.
    PLoS One. 2016;11:e0147736.
    PubMed     Text format     Abstract available


  108. GUNGOR B, Adiguzel E, Gursel I, Yilmaz B, et al
    Intestinal Microbiota in Patients with Spinal Cord Injury.
    PLoS One. 2016;11:e0145878.
    PubMed     Text format     Abstract available


  109. GLOUX K, Anba-Mondoloni J
    Unique beta-Glucuronidase Locus in Gut Microbiomes of Crohn's Disease Patients and Unaffected First-Degree Relatives.
    PLoS One. 2016;11:e0148291.
    PubMed     Text format     Abstract available


  110. EHRENPREIS ED, Zhou Y, Alexoff A, Melitas C, et al
    Effect of the Diagnosis of Inflammatory Bowel Disease on Risk-Adjusted Mortality in Hospitalized Patients with Acute Myocardial Infarction, Congestive Heart Failure and Pneumonia.
    PLoS One. 2016;11:e0158926.
    PubMed     Text format     Abstract available


  111. KOL A, Walker NJ, Nordstrom M, Borjesson DL, et al
    Th17 Pathway As a Target for Multipotent Stromal Cell Therapy in Dogs: Implications for Translational Research.
    PLoS One. 2016;11:e0148568.
    PubMed     Text format     Abstract available


  112. KOH SJ, Choi Y, Kim BG, Lee KL, et al
    Matricellular Protein Periostin Mediates Intestinal Inflammation through the Activation of Nuclear Factor kappaB Signaling.
    PLoS One. 2016;11:e0149652.
    PubMed     Text format     Abstract available


  113. CUI Y, Wei H, Lu F, Liu X, et al
    Different Effects of Three Selected Lactobacillus Strains in Dextran Sulfate Sodium-Induced Colitis in BALB/c Mice.
    PLoS One. 2016;11:e0148241.
    PubMed     Text format     Abstract available


  114. VISSCHEDIJK MC, Alberts R, Mucha S, Deelen P, et al
    Pooled Resequencing of 122 Ulcerative Colitis Genes in a Large Dutch Cohort Suggests Population-Specific Associations of Rare Variants in MUC2.
    PLoS One. 2016;11:e0159609.
    PubMed     Text format     Abstract available


  115. ZHAO X, Li N, Ren Y, Ma T, et al
    Efficacy and Safety of Beclomethasone Dipropionate versus 5-Aminosalicylic Acid in the Treatment of Ulcerative Colitis: A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0160500.
    PubMed     Text format     Abstract available


  116. STAWOWCZYK E, Kawalec P, Pilc A
    Cost-Effectiveness Analysis of 1-Year Treatment with Golimumab/Standard Care and Standard Care Alone for Ulcerative Colitis in Poland.
    PLoS One. 2016;11:e0160444.
    PubMed     Text format     Abstract available


  117. KHAN IA, Pilli S, A S, Rampal R, et al
    Prevalence and Association of Mycobacterium avium subspecies paratuberculosis with Disease Course in Patients with Ulcero-Constrictive Ileocolonic Disease.
    PLoS One. 2016;11:e0152063.
    PubMed     Text format     Abstract available


  118. BEN-SHACHAR S, Yanai H, Sherman Horev H, Elad H, et al
    MicroRNAs Expression in the Ileal Pouch of Patients with Ulcerative Colitis Is Robustly Up-Regulated and Correlates with Disease Phenotypes.
    PLoS One. 2016;11:e0159956.
    PubMed     Text format     Abstract available


  119. STEIN AC, Gaetano JN, Jacobs J, Kunnavakkam R, et al
    Northern Latitude but Not Season Is Associated with Increased Rates of Hospitalizations Related to Inflammatory Bowel Disease: Results of a Multi-Year Analysis of a National Cohort.
    PLoS One. 2016;11:e0161523.
    PubMed     Text format     Abstract available


  120. RANDALL K, Henderson N, Reens J, Eckersley S, et al
    Claudin-2 Expression Levels in Ulcerative Colitis: Development and Validation of an In-Situ Hybridisation Assay for Therapeutic Studies.
    PLoS One. 2016;11:e0162076.
    PubMed     Text format     Abstract available


  121. NIRVANAPPA AC, Mohan CD, Rangappa S, Ananda H, et al
    Novel Synthetic Oxazines Target NF-kappaB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo.
    PLoS One. 2016;11:e0163209.
    PubMed     Text format     Abstract available


  122. BEN-SHACHAR S, Yanai H, Sherman Horev H, Elad H, et al
    Correction: MicroRNAs Expression in the Ileal Pouch of Patients with Ulcerative Colitis Is Robustly Up-Regulated and Correlates with Disease Phenotypes.
    PLoS One. 2016;11:e0165220.
    PubMed     Text format     Abstract available


  123. VICKERS AD, Ainsworth C, Mody R, Bergman A, et al
    Systematic Review with Network Meta-Analysis: Comparative Efficacy of Biologics in the Treatment of Moderately to Severely Active Ulcerative Colitis.
    PLoS One. 2016;11:e0165435.
    PubMed     Text format     Abstract available


  124. HSU TY, Shih HM, Wang YC, Lin LC, et al
    Effect of Alcoholic Intoxication on the Risk of Inflammatory Bowel Disease: A Nationwide Retrospective Cohort Study.
    PLoS One. 2016;11:e0165411.
    PubMed     Text format     Abstract available


  125. SUNDARRAJAN S, Arumugam M
    Comorbidities of Psoriasis - Exploring the Links by Network Approach.
    PLoS One. 2016;11:e0149175.
    PubMed     Text format     Abstract available


  126. LO WC, Arsenescu V, Arsenescu RI, Friedman A, et al
    Inflammatory Bowel Disease: How Effective Is TNF-alpha Suppression?
    PLoS One. 2016;11:e0165782.
    PubMed     Text format     Abstract available


  127. MANGUSO F, Bennato R, Lombardi G, Riccio E, et al
    Efficacy and Safety of Oral Beclomethasone Dipropionate in Ulcerative Colitis: A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0166455.
    PubMed     Text format     Abstract available


  128. CHIAPPONI C, Witt M, Dlugosch GE, Gulberg V, et al
    The Perception of Physician Empathy by Patients with Inflammatory Bowel Disease.
    PLoS One. 2016;11:e0167113.
    PubMed     Text format     Abstract available


  129. DONG J, Teng G, Wei T, Gao W, et al
    Methodological Quality Assessment of Meta-Analyses and Systematic Reviews of Probiotics in Inflammatory Bowel Disease and Pouchitis.
    PLoS One. 2016;11:e0168785.
    PubMed     Text format     Abstract available


  130. ZHANG F, Xu C, Ning L, Hu F, et al
    Exploration of Serum Proteomic Profiling and Diagnostic Model That Differentiate Crohn's Disease and Intestinal Tuberculosis.
    PLoS One. 2016;11:e0167109.
    PubMed     Text format     Abstract available


  131. ZEITZ J, Ak M, Muller-Mottet S, Scharl S, et al
    Pain in IBD Patients: Very Frequent and Frequently Insufficiently Taken into Account.
    PLoS One. 2016;11:e0156666.
    PubMed     Text format     Abstract available


    January 2015
  132. MARSHALL DC, Lyman SK, McCauley S, Kovalenko M, et al
    Selective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal Cancer.
    PLoS One. 2015;10:e0127063.
    PubMed     Text format     Abstract available


  133. CORTES X, Borras-Blasco J, Moles JR, Bosca M, et al
    Safety of ferric carboxymaltose immediately after infliximab administration, in a single session, in inflammatory bowel disease patients with iron deficiency: a pilot study.
    PLoS One. 2015;10:e0128156.
    PubMed     Text format     Abstract available


  134. CHENG Y, Zhu Y, Huang X, Zhang W, et al
    Association between TLR2 and TLR4 Gene Polymorphisms and the Susceptibility to Inflammatory Bowel Disease: A Meta-Analysis.
    PLoS One. 2015;10:e0126803.
    PubMed     Text format     Abstract available


  135. LOREN V, Cabre E, Ojanguren I, Domenech E, et al
    Interleukin-10 Enhances the Intestinal Epithelial Barrier in the Presence of Corticosteroids through p38 MAPK Activity in Caco-2 Monolayers: A Possible Mechanism for Steroid Responsiveness in Ulcerative Colitis.
    PLoS One. 2015;10:e0130921.
    PubMed     Text format     Abstract available


  136. BOYD HA, Basit S, Harpsoe MC, Wohlfahrt J, et al
    Inflammatory Bowel Disease and Risk of Adverse Pregnancy Outcomes.
    PLoS One. 2015;10:e0129567.
    PubMed     Text format     Abstract available


  137. TAKAYAMA T, Okamoto S, Hisamatsu T, Naganuma M, et al
    Computer-Aided Prediction of Long-Term Prognosis of Patients with Ulcerative Colitis after Cytoapheresis Therapy.
    PLoS One. 2015;10:e0131197.
    PubMed     Text format     Abstract available


  138. LU C, Yang J, Yu W, Li D, et al
    Association between 25(OH)D Level, Ultraviolet Exposure, Geographical Location, and Inflammatory Bowel Disease Activity: A Systematic Review and Meta-Analysis.
    PLoS One. 2015;10:e0132036.
    PubMed     Text format     Abstract available


  139. CARMO AM, Santos FM, Ortiz-Agostinho CL, Nishitokukado I, et al
    Correction: Cytomegalovirus Infection in Inflammatory Bowel Disease Is Not Associated with Worsening of Intestinal Inflammatory Activity.
    PLoS One. 2015;10:e0133102.
    PubMed     Text format     Abstract available


  140. JOHANNSEN A, Fored MC, Hakansson J, Ekbom A, et al
    Consumption of Dental Treatment in Patients with Inflammatory Bowel Disease, a Register Study.
    PLoS One. 2015;10:e0134001.
    PubMed     Text format     Abstract available


  141. DAMMAN CJ, Brittnacher MJ, Westerhoff M, Hayden HS, et al
    Low Level Engraftment and Improvement following a Single Colonoscopic Administration of Fecal Microbiota to Patients with Ulcerative Colitis.
    PLoS One. 2015;10:e0133925.
    PubMed     Text format     Abstract available


  142. LORD JD, Shows DM, Chen J, Thirlby RC, et al
    Human Blood and Mucosal Regulatory T Cells Express Activation Markers and Inhibitory Receptors in Inflammatory Bowel Disease.
    PLoS One. 2015;10:e0136485.
    PubMed     Text format     Abstract available


  143. LEE SY, Lee SH, Yang EJ, Kim EK, et al
    Metformin Ameliorates Inflammatory Bowel Disease by Suppression of the STAT3 Signaling Pathway and Regulation of the between Th17/Treg Balance.
    PLoS One. 2015;10:e0135858.
    PubMed     Text format     Abstract available


  144. ODAHARA S, Uchiyama K, Kubota T, Ito Z, et al
    A Prospective Study Evaluating Metabolic Capacity of Thiopurine and Associated Adverse Reactions in Japanese Patients with Inflammatory Bowel Disease (IBD).
    PLoS One. 2015;10:e0137798.
    PubMed     Text format     Abstract available


  145. HUBENTHAL M, Hemmrich-Stanisak G, Degenhardt F, Szymczak S, et al
    Sparse Modeling Reveals miRNA Signatures for Diagnostics of Inflammatory Bowel Disease.
    PLoS One. 2015;10:e0140155.
    PubMed     Text format     Abstract available


  146. CLOSE H, Mason JM, Wilson DW, Hungin AP, et al
    Risk of Ischaemic Heart Disease in Patients with Inflammatory Bowel Disease: Cohort Study Using the General Practice Research Database.
    PLoS One. 2015;10:e0139745.
    PubMed     Text format     Abstract available


  147. EARLEY H, Lennon G, Balfe A, Kilcoyne M, et al
    A Preliminary Study Examining the Binding Capacity of Akkermansia muciniphila and Desulfovibrio spp., to Colonic Mucin in Health and Ulcerative Colitis.
    PLoS One. 2015;10:e0135280.
    PubMed     Text format     Abstract available


  148. HISAMATSU T, Ono N, Imaizumi A, Mori M, et al
    Decreased Plasma Histidine Level Predicts Risk of Relapse in Patients with Ulcerative Colitis in Remission.
    PLoS One. 2015;10:e0140716.
    PubMed     Text format     Abstract available


  149. SKOVDAHL HK, Granlund Av, Ostvik AE, Bruland T, et al
    Expression of CCL20 and Its Corresponding Receptor CCR6 Is Enhanced in Active Inflammatory Bowel Disease, and TLR3 Mediates CCL20 Expression in Colonic Epithelial Cells.
    PLoS One. 2015;10:e0141710.
    PubMed     Text format     Abstract available


  150. RANJHA R, Aggarwal S, Bopanna S, Ahuja V, et al
    Site-Specific MicroRNA Expression May Lead to Different Subtypes in Ulcerative Colitis.
    PLoS One. 2015;10:e0142869.
    PubMed     Text format     Abstract available


  151. DONG J, Chen Y, Tang Y, Xu F, et al
    Body Mass Index Is Associated with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    PLoS One. 2015;10:e0144872.
    PubMed     Text format     Abstract available


  152. BANK S, Andersen PS, Burisch J, Pedersen N, et al
    Polymorphisms in the Toll-Like Receptor and the IL-23/IL-17 Pathways Were Associated with Susceptibility to Inflammatory Bowel Disease in a Danish Cohort.
    PLoS One. 2015;10:e0145302.
    PubMed     Text format     Abstract available


  153. ALEANDRI M, Conte MP, Simonetti G, Panella S, et al
    Influenza A Virus Infection of Intestinal Epithelial Cells Enhances the Adhesion Ability of Crohn's Disease Associated Escherichia coli Strains.
    PLoS One. 2015;10:e0117005.
    PubMed     Text format     Abstract available


  154. ROSSI O, Khan MT, Schwarzer M, Hudcovic T, et al
    Faecalibacterium prausnitzii Strain HTF-F and Its Extracellular Polymeric Matrix Attenuate Clinical Parameters in DSS-Induced Colitis.
    PLoS One. 2015;10:e0123013.
    PubMed     Text format     Abstract available


  155. GOUNARIS E, Heiferman MJ, Heiferman JR, Shrivastav M, et al
    Zileuton, 5-lipoxygenase inhibitor, acts as a chemopreventive agent in intestinal polyposis, by modulating polyp and systemic inflammation.
    PLoS One. 2015;10:e0121402.
    PubMed     Text format     Abstract available


  156. CATANZARO D, Rancan S, Orso G, Dall'Acqua S, et al
    Boswellia serrata Preserves Intestinal Epithelial Barrier from Oxidative and Inflammatory Damage.
    PLoS One. 2015;10:e0125375.
    PubMed     Text format     Abstract available


  157. KRABS RU, Enk R, Teich N, Koelsch S, et al
    Autonomic effects of music in health and Crohn's disease: the impact of isochronicity, emotional valence, and tempo.
    PLoS One. 2015;10:e0126224.
    PubMed     Text format     Abstract available


  158. KUO CL, Vsevolozhskaya OA, Zaykin DV
    Assessing the Probability that a Finding Is Genuine for Large-Scale Genetic Association Studies.
    PLoS One. 2015;10:e0124107.
    PubMed     Text format     Abstract available


  159. VENTHAM NT, Gardner RA, Kennedy NA, Shubhakar A, et al
    Changes to serum sample tube and processing methodology does not cause Intra-Individual [corrected] variation in automated whole serum N-glycan profiling in health and disease.
    PLoS One. 2015;10:e0123028.
    PubMed     Text format     Abstract available


  160. VADASZ Z, Rainis T, Nakhleh A, Haj T, et al
    The Involvement of Immune Semaphorins in the Pathogenesis of Inflammatory Bowel Diseases (IBDs).
    PLoS One. 2015;10:e0125860.
    PubMed     Text format     Abstract available


  161. COCKRELL RC, Christley S, Chang E, An G, et al
    Towards anatomic scale agent-based modeling with a massively parallel spatially explicit general-purpose model of enteric tissue (SEGMEnT_HPC).
    PLoS One. 2015;10:e0122192.
    PubMed     Text format     Abstract available


  162. ANDREASSEN OA, Desikan RS, Wang Y, Thompson WK, et al
    Abundant genetic overlap between blood lipids and immune-mediated diseases indicates shared molecular genetic mechanisms.
    PLoS One. 2015;10:e0123057.
    PubMed     Text format     Abstract available


  163. TEDJO DI, Jonkers DM, Savelkoul PH, Masclee AA, et al
    The effect of sampling and storage on the fecal microbiota composition in healthy and diseased subjects.
    PLoS One. 2015;10:e0126685.
    PubMed     Text format     Abstract available


  164. HANG J, Cai B, Xue P, Wang L, et al
    The Joint Effects of Lifestyle Factors and Comorbidities on the Risk of Colorectal Cancer: A Large Chinese Retrospective Case-Control Study.
    PLoS One. 2015;10:e0143696.
    PubMed     Text format     Abstract available


    January 2014
  165. FREHN L, Jansen A, Bennek E, Mandic AD, et al
    Distinct patterns of IgG and IgA against food and microbial antigens in serum and feces of patients with inflammatory bowel diseases.
    PLoS One. 2014;9:e106750.
    PubMed     Text format     Abstract available


  166. PELLISSIER S, Dantzer C, Mondillon L, Trocme C, et al
    Relationship between Vagal Tone, Cortisol, TNF-Alpha, Epinephrine and Negative Affects in Crohn's Disease and Irritable Bowel Syndrome.
    PLoS One. 2014;9:e105328.
    PubMed     Text format     Abstract available


  167. CANAVAN C, Card T, West J
    The Incidence of Other Gastroenterological Disease following Diagnosis of Irritable Bowel Syndrome in the UK: A Cohort Study.
    PLoS One. 2014;9:e106478.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: